The Department of Health and Social Care, in its response to a consultation on the availability of puberty blockers, says the ban is being made indefinite following advice from the Commission on Human Medicines (CHM).
The ban applies to puberty suppressants via private prescriptions for the treatment of gender incongruence and dysphoria. The decision will next be reviewed in 2027.
“We know this news may be upsetting, particularly for trans youth and their loved ones,” said trans youth support charity Mermaids.
“We are deeply disappointed that the UK government has decided to continue criminalising the prescription of puberty suppressing medicines for trans children and young people,” it added.
Register Now to Continue Reading
Thank you for visiting Children & Young People Now and making use of our archive of more than 60,000 expert features, topics hubs, case studies and policy updates. Why not register today and enjoy the following great benefits:
What's Included
-
Free access to 4 subscriber-only articles per month
-
Email newsletter providing advice and guidance across the sector
Already have an account? Sign in here
